BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 28, 2020
View Archived Issues
Novel variant linked to childhood steroid-sensitive nephrotic syndrome
Read More
HanaVax, University of Tokyo present mutated Pneumococcal surface proteins
Read More
New CD73 inhibitors synthesized at Eternity Bioscience
Read More
J2H Biotech, Ahn-Gook Pharmaceutical describe new mirabegron prodrugs
Read More
University of Florida identifies new PRMT5 inhibitors
Read More
Shanghai Hansoh Biomedical, Jiangsu Hansoh Pharmaceutical patent ERK-1/2 inhibitors
Read More
Dimerix announces positive data from phase II ACTION trials of DMX-200 in kidney disease
Read More
Global phase III PolarisDMD trial of edasalonexent does not meet primary endpoint
Read More
XL-092: a promising pan-tyrosine kinase inhibitor in clinical development
Read More
First patient enrolled in the immune modulation domain of REMAP-COVID substudy
Read More
Prilenia initiates enrollment in phase III PROOF-HD trial of pridopidine
Read More
New phase I/Ib study to evaluate GEN-001 with avelumab for solid tumors
Read More
Positive 6-month interim analysis data presented from TOPAZ phase II study of SRK-015
Read More
Alzheon studies ALZ-801 in phase II biomarker study for early Alzheimer's
Read More
UKRI conditionally approves grant funding to explore SDC-1801 as treatment of COVID-19
Read More
SIMR-1281: a novel candidate for clinical trials in cancer
Read More
ASHG 2020: New inflammatory disease, and maybe, a new classification system
Read More
First-in-human data presented for TPX-0022
Read More
FDA clears IND for phase Ib study of bempegaldesleukin for COVID-19
Read More
Spero Therapeutics' SPR-720 shows promise in phase I study
Read More
Voclosporin studied for antiviral effects in kidney transplant recipients with COVID-19
Read More
Apollomics reports phase I data for APL-101
Read More
FDA approves Eysuvis for short-term treatment of dry eye disease
Read More
Valo Therapeutics describes design and preclinical results with neoantigen-coated oncolytic viruses
Read More
Novel selective TRK degraders effectively reduce TPM3-TRKA fusion protein levels
Read More
New pilot study to evaluate afamelanotide for arterial ischemic stroke
Read More
Histogen and Amerimmune collaborate to study emricasan for COVID-19
Read More